The Coulter STKS mean platelet volume (MPV), platelet distribution width (PDW), mean corpuscular volume (MCV), and hematocrit (HCT) are assessed in thrombotic diseases. Complete blood counts (CBCs) were studied retrospectively in 645 consecutive hospital cases and, 850 "CBCs with blood films to the pathologist." Because the MPV and PDW are time dependant, nomograms and tables were created for the 0-25- and 26-40-min elapsed time intervals. In this study, abnormal CBC platelet parameters were found in the majority of patients with common thrombotic diseases, such as diabetes, atherosclerosis, hypertension, congestive heart failure, deep vein thrombosis (DVT), and toxemia. Thrombotic disease-related CBC categories include combined elevated MPV and PDW, elevated MPV or PDW alone, "MCV/MPV mismatch" (failure of physiologic "MCV/MPV match"), rheologic problem of elevated HCT and MPV, and mild thrombocytopenia with decreased MPV and high PDW. Anticoagulants and steroids often decrease the MPV. CBC platelet parameter abnormalities provide a new useful classification of thrombotic diseases in daily practice.
Jackson SR, Carter JM, et al. Platelet volume: laboratory measurement and clinical application , Blood Rev1993;7:104.
2.
Threatte GAUsefulness of the mean platelet volume. Clin Lab Med1993;13:937.
3.
Willans DJ, Power-Fardy W., Mill SC, et al. Patients with elevated mean platelet volumes incur thrombotic events (abstract). Am J Clin Pathol1993;100:337.
4.
Willans DJ, Mill SC, Palmer B., et al. The MCV/MPV mismatch: a rheological problem associated with thrombotic events (abstract). Am J Clin Pathol1994;102:544.
5.
Hirsh J.Guidelines for Antithrombotic Therapy. Hamilton, Ontario: Decker Periodicals, 1993.
6.
Zucker-Franklin D.Morphology of megakaryocytes and platelets . In: Williams WJ, Beutler E, Erslev AJ, et al., eds. Hematology (fourth edition). New York : McGraw-Hill, 1990:1161.
7.
Schneider W. , Gattermann N.Megakaryocytes: origin of bleeding and thrombotic disorders. Eur J Clin Invest1994;24(suppl. 1): 16.
8.
Jackson CWRole and evaluation of megakaryocytes and platelets in cardiovascular disease. A meeting perspective (commentary). Eur J Clin Invest1994;24:100.
9.
Holmsen H.Significance of testing platelet functions in vitro. Eur J Clin Invest1994;24(suppl. 1):3.
10.
Riess H., Riewald M.The clinical impact of platelet function testing. Thromb Res1994;74(suppl. 1):S69.
11.
Hutt R., Ogunniyi SO, Sullivan Mhf, et al. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol1994;83:146.
12.
O'Grady JG, Harding B., Stevens FM, et al. Influence of splenectomy and the functional hyposplenism of coeliac disease on platelet count and volume. Scand J Haematol1985; 34:425.
13.
Chamberlain KG, Tong M., Penington DGProperties of the exchangeable splenic platelets released into the circulation during exercise-induced thrombocytosis . Am J Hematol1990;34:161.
14.
Bessman JD, Williams LJ, Gilmer PR Jr.Platelet size in health and hematologic disease . Am J Clin Pathol1982;78: 150.
15.
Bessman JD, Gilmer PR Jr, Gardner FHUse of mean platelet volume improves detection of platelet disorders . Blood Cells1985;11:127.
16.
Berk PD, Goldberg JD, Donovan PB, et al. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols. Semin Hematol1986;23:132.
17.
Garg SK, Lackner H., Karpatkin S.The increased percentage of megathrombocytes in various clinical disorders . Ann Intern Med1972 ;77:361.
18.
Rao AK, Goldberg RE, Walsh PNPlatelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant activity and platelet volume. J Lab Clin Med1984;103:82.
von Ruecker A. , Hufnagel P., Dickerhoff R., et al. Qualitative and quantitative changes in platelets after coronary-artery bypass surgery may help identify thrombotic complications and infections. Klin Wochenschr1989;67:1042.
21.
Smyth DW, Martin JF, Michalis L., et al. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest1993;23:361.
22.
Martin JF, Bath Pmw, Burr MLInfluence of platelet size on outcome after myocardial infarction . Lancet1991;338: 1409.
23.
Burr ML, Holliday RM, Fehily AM, et al. Haematologic prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J1992;13:166.
24.
Schultheiss HP, Tschoepe D., Esser J., et al. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest1994;24:243.
25.
D'Erasmo E. , Aliberti G., Celi FS, et al. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction . J Intern Med1990;227:11.
26.
Weder AB, Schmouder RL, Torretti BAPlatelet volume responses to cytoplasmic acidification in essential hypertension . J Hypertens1990;8:1137.
27.
Sharpe PC, Desai ZR, Morris Tcm.Increase in mean platelet volume-in patients with chronic renal failure treated with erythropoietin. J Clin Pathol1994;47:159.
28.
Leonard ELRheology of thrombosis. In: Colman RW, Hirsh J, Marder VJ, et al., eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice (third edition). Philadelphia: JB Lippincott, 1994:1211.
29.
Carter CJThe pathophysiology of venous thrombosis. Prog Cardiovasc Dis1994;36:439.
30.
Bick RLAcquired platelet function defects. Hematol Oncol Clin North Am1992;6:1203.
31.
Bick RLPlatelet function defects: a clinical review. Semin Thromb Hemost1992;18:167.
32.
Brown AS, Martin JFThe megakaryocyte platelet system and vascular disease. Eur J Clin Invest1994;24(Suppl. 1):9.
33.
Bick RL, McClain BJPlatelet indices as markers of acute thrombosis and response to antithrombotic therapy (abstract). Thromb Haemost1983;50:153.
